SUMMARY Of 78 comparative studies of plasma catecholamines in patients with essential hypertension and in normotensive controls, most reported higher catecholamine levels in the hypertensives, although only about 40% of the studies were positive (reporting statistically significant hypertensivenormotensive differences). Although there was dramatic variability in catecholamine values within and across studies, virtually all studies of norepinephrine in young, consistently hypertensive patients were positive. The likelihood that a study was positive with respect to norepinephrine was independent of the likelihood with respect to epinephrine, so that total catecholamine values, or else the sum of norepinephrine plus epinephrine, differentiated hypertensives from normotensives to a greater extent than levels of either substance alone. The preponderance of literature on the subject supports the hypothesis that increased plasma catecholamine concentrations occur in some patients with essential hypertension. Elevated plasma norepinephrine in relatively young, established hypertensive patients is consistent with a pathophysiologic role for increased sympathetic neural activity in this subgroup. T HE possible pathophysiologic role of excessive sympathetic nervous system activity in essential hypertension has aroused persistent interest and controversy. More than 75 studies have compared levels of norepinephrine (NE), the neurotransmitter of the sympathetic nervous system, or epinephrine (E), secreted by the adrenal medulla, in patients with essential hypertension and in normotensive controls.
T HE possible pathophysiologic role of excessive sympathetic nervous system activity in essential hypertension has aroused persistent interest and controversy. More than 75 studies have compared levels of norepinephrine (NE), the neurotransmitter of the sympathetic nervous system, or epinephrine (E), secreted by the adrenal medulla, in patients with essential hypertension and in normotensive controls. 1 " 78 No consensus has emerged about whether patients with essential hypertension show abnormal sympathetic neural or sympathoadrenomedullary activity as indicated by plasma catecholamine levels.
The problem is quite complex, for at least three reasons. First, plasma catecholamines are difficult to measure. The assay techniques can be tedious and capricious; the concentrations of NE and especially of E are extremely small, averaging about 250 and 50 pg/ml respectively; and blood samples have to be handled carefully to avoid oxidation of the catecholamines.
CATECHOLAMINES IN HYPERTENSION/GoWsfdn
This analysis updates, extends, and refines a previous one that was based on 32 studies of NE 81 alone and did not consider plasma E, dopamine (DA), or total catecholamines (TC). Since then, an additional 32 studies of NE have been completed, allowing consideration of factors that could not be analyzed in the previous review. In addition, 31 studies of E, six of DA, and 12 of TC have been analyzed separately in the current review.
of the mean (SEM) by multiplying the SEM by the square root of the number of observations. Statistical testing used independent-and dependent-means t tests, Pearson correlation coefficients, and chi-squared analyses. 84 In one case, results from two separate publications 27 ' 28 were grouped together because only then was an entire hypertensive group represented, as opposed to subgroups based on renin profiling.
Methods
To locate the reviewed studies, I conducted MED-LINE searches for interactions among NE, E, catecholamines, and hypertension, and then culled additional articles using the bibliographies of the listed publications.
The reviewed studies satisfied these criteria: 1) they were published as journal articles in English since 1970; 2) they included both a group of patients with essential hypertension and a normotensive control group; 3) they reported plasma NE, E, DA, or TC in resting, supine individuals; and 4) they used a sensitive and specific assay technique, either a radioenzymatic (R) procedure, a modern fluorimetric (F) method such as that of Renzini et al. , M or high pressure liquid chromatography with electrochemical detection. 83 Abstracts and obvious duplications were excluded.
The large number of published studies allowed a statistical approach in which each study provided single data points for the hypertensive and normotensive groups, with comparisons conducted across studies for factors of interest.
When necessary, mean group catecholamine values were derived from figures, or from the weighted contributions of listed subgroups; and group standard deviations (SD) were calculated from the standard errors Results Noreplnephrine Table 1 displays summary statistics about hypertensive and normotensive mean NE levels from 64 studies. Data from the individual studies are tabulated by assay type in table 2. Of the 64 studies, 52 (81%) reported higher levels in the hypertensives, by an average of 55 pg/ml (/ = 6.75, p< 0.001). In view of the pronounced interindividual variabilty of NE levels, such a small mean H-N difference could easily not have been statistically significant in many studies. And, in fact, only 25 (39%) of the 64 studies were positive with respect to NE. Since about two-fifths of the studies were positive and about three-fifths were negative, one can appreciate that any generalizations from the literature might be questioned.
If there were a variably represented "hypernoradrenergic" subgroup of hypertensives, then studies with a preoponderance of these patients should have been positive due to the excessive mean NE levels in the hypertensive groups. Across the 64 studies, the mean hypertensive NE level of the positive studies was in fact higher than that of the negative studies (307 vs 258 pg/ml, t = 2.16, p < 0.05).
A preponderance of hypernoradrenergic hypertensives in positive studies would mean that the positive H   200  289  302  436  294  280  390  56  71   N   146  227  260  353  239  225  255  43  65   SDH   95  142  162  156  150  140  172  45  63   SD N   45  119  142  94  128  113  72  38  45   n   11  34  18  1  52  64  12 ns H = hypertensive groups; N = normotensive groups; SD = average group standard deviation; / = dependent-means t value; NE = norepinephrine; E = epinephrine; DA = dopamine; TC = total catecholamines; R = radioenzymatic; COMT = catechol-O-methyltransferase radioenzymatic; PNMT = phenylethanolamine-N-methyltransferase radioenzymatic; HPLC = high pressure liquid chromatography with electrochemical detection; p = probability of statistical significance for the hypertensive-normotensive mean difference in catecholamine concentrations. All mean values expressed in pg/ml. FitzGerald (30) Henry (37) Hofman (39) Hofman (40) Jones (42) Kafka (43) Lake (51) Lake (52) Lake (53) Lake (54) Lake (55) Ogawa (64) Parfrey (65) Sever (71) Sever (72) Taylor ( •Statistically significant hypertensive-normotensive difference in heart rate or norepinephrine, with p < 0.05.
studies would also have a larger hypertensive SD than normotensive SD, while the negative studies would have a hypertensive and normotensive SD that was about equal. Overall, the ratio of hypertensive to normotensive SD was larger in the positive studies (1.82 vs 1.28, t = 3.23, p < 0.01). If selection or treatment factors resulted in relatively low control group mean NE levels in some studies, those studies would have tended to be positive. Normotensive control NE levels indeed were lower in the positive studies (191 vs 246 pg/ml, t = 3.33, p < 0.01).
Finally, if studies differed in the extent of control over environmental factors, then the more carefully controlled studies should have been positive due to a lower SD across individuals. The average SD of normotensive NE levels was in fact smaller in the positive studies (87 vs 129 pg/ml, t = 2.58, p < 0.05).
Study Size
Of 29 studies with less than 50 subjects, 14 (48%) were positive, and of 35 with 50 or more subjects, 11 (31%) were positive -a nonsignificant difference in proportions. The average SD of the NE values was also similar in the two types of study size. The size of the study was therefore unrelated to the likelihood of obtaining positive results.
Type of Assay
In contrast, hypertensive and normotensive group NE levels, and the likelihood of obtaining positive results, were related to the type of assay technique used. Of 11 studies using a fluorimetric (F) assay technique, eight (73%) were positive, while only 17 of 35 (33%) using a radioenzymatic (R) assay technique were positive (x 2 = 4.40, p < 0.05). The average NE level was significantly higher in the R than F studies for both hypertensive (294 vs 200 pg/ml, t = 3.86, p < 0.001) and normotensive (239 vs 146 pg/ml, t = 4.11, p < 0.001) groups. The mean H-N differences, though, were virtually identical in the F (54 pg/ml) and R (55 pg/ml) studies. The average SD of NE levels was significantly greater in the R studies for both hypertensive (150 vs 95 pg/ml, t = 3.39, p < 0.01) and especially for normotensive (128 vs 45 pg/ml, t = 4.29, p < 0.001) groups.
Because positive studies were weighted disproportionately by the results derived from fluorimetric assay techniques, positive and negative studies were compared within assay techniques. Among F studies, mean hypertensive NE levels were higher in positive than negative studies (212 vs 168 pg/ml, t = 2.93, p < 0.05). Among R studies, the same finding occurred: mean hypertensive NE levels were higher in the positive studies (351 vs261 pg/ml, t = 4.21, p< 0.001), especially among studies using the catechol-O-methyltransferase (COMT) radioenzymatic assay technique, where the mean hypertensive NE level was 359 pg/ml in the positive studies and 251 pg/ml in the negative (t = 4.39, p < 0.001). Thus, when analyzed separately within assay types, the data were consistent with the presence of some hypernoradrenergic patients among the population of hypertensives.
The age of the hypertensive patients differentiated the F and R studies. All seven F studies listing the hypertensives' mean age reported a mean age less than or equal to 40 years old; while among 43 R studies, only 11 reported a mean hypertensive age less than or equal to 40 years (x 2 = 10.85, p < 0.01). Inclusion of relatively young hypertensives appears to have contributed to the high frequency of positive results associated with the F type of assay.
Given the relatively small H-N differences in NE, it should not be surprising that those studies reporting a large SD as a percent of the group mean tended to be negative. When the SD was expressed as a percent of the mean for the hypertensive and normotensive groups, among hypertensives the proportion of F studies where the SD was less than 50% of the mean did not differ from the corresponding proportion of R studies (60% for F, 49% for R). However, among normotensives, eight of 10 (80%) F studies reported an SD less than 40% of the mean, while only 13 of 47 (28%) R studies did so (x 2 = 7.35,/? < 0.01). Radioenzymatic studies, therefore, reported higher standard deviations of normotensive norepinephrine levels when expressed as a percent of the mean.
Patient Age
Across the 51 studies that listed patient ages, the hypertensive groups were slighty but consistently older, by an average of 2.6 years (t = 4.50, p < 0.001). Mean group age correlated significantly with mean plasma NE across the normotensive but not the hypertensive groups (r = 0.29, p < 0.05, and r = 0.01, p = ns).
An artifactual effect of poor age matching would require that positive studies include hypertensives who were older than normotensives, and negative studies include groups of similar age. The correlation between the difference in group mean ages and the difference in group mean NE levels, however, was nil. Further, in view of the small or absent slopes of the regression lines relating NE with age (7.7 pg/yr in normotensives, 0.4 pg/yr in hypertensives), only a grossly large age mismatch would produce the obtained average H-N difference in norepinephrine; the average actual age mismatch was too small to do so. Hypertensive-normotensive differences in positive studies did not, therefore, derive from the artifactual effects of poor age matching.
Since plasma NE increased with age across the normotensive but not hypertensive groups, one would predict that positive results would tend to occur in studies of relatively younger patients. This was exactly the case. When the hypertensive group mean age was less than 30 years, four of five (80%) studies were positive; when it was 30 to 39 years, seven of 11 (64%) were positive; 40 to 49 years, seven of 30 (23%) were positive; and 50 years or more, one of four (25%) was positive. Figure 1 shows that in studies where both the hypertensive and normotensive groups averaged 40 years old or less, the hypertensives virtually always showed higher plasma NE (t = 5.07, p < 0.001), while in studies where both groups averaged more than 40 years, H-N differences were smaller and less consistent, because the normotensives showed increased NE with age (t = 3.09, p < 0.01). Further, the data from six otherwise negative studies 4 only among relatively young patients. These findings demonstrate rather conclusively that a proportion of young patients with essential hypertension show elevated NE. Table 3 shows reported correlations between NE and age in 48 hypertensive and normotensive groups. Among normotensive groups, age tended to correlate with NE whether the study was positive or not: five of 8 (63%) positive studies reported significant age-NE correlations in the normotensive groups, while 10 of 15 (67%) negative studies did so.
While the majority of normotensive groups showed a significant age-NE relationship, the majority of hypertensive groups did not (16 of 24 studies, x 2 = 4.77, p < 0.05) compared with normotensive groups. This discrepancy can be accounted for, once again, by relatively elevated NE levels in some young hypertensives. When the six above-mentioned studies commenting on the existence of such a subgroup were considered to be positive, then 11 of 13 (85%) positive studies reported no significant age-NE relationship in the hypertensive groups, while six of 11 (55%) negative studies did (x 2 = 2.91, 0.05 < p < 0.10).
Sex
Although most studies have listed the sex distribution of the hypertensive and normotensive groups, relatively few have presented data separately by sex. The mean male:female ratio in 16 positive studies was 2.10:1, not significantly different from the ratio in 25 negative studies, 1.80:1. Thus, even if plasma norepinephnne differed between the sexes, this could not account for the obtained H-N differences in NE.
Race
Only eight studies listed the racial makeup of the study population. In five (three positive and two negative), all the patients were white. Of the remaining Bertel (4) Brecht (7) deChamplain (14) DeLeeuw (18 Young hypemoradrenergic Young hypernoradrenergic ns = not statistically significant; sig = statistically significant, p < 0.05; young hypernoradrenergic = otherwise negative study reporting significant hypertensive-normotensive difference in norepinephrine specifically in young age groups. When necessary, average correlation coefficients were calculated from subgroups using Fisher's z-primed transformation (see ref. 84 ).
•Statistically significant, p < 0.05.
three studies, only one 72 systematically presented data separately by race in a large number of patients. In this study, no significant difference in NE was obtained between black and white hypertensives, although black hypertensives showed an age-NE relationship and white hypertensives did not.
Body Weight
Eleven studies reported the mean weight of the hypertensive and normotensive groups, and all 11 reported that the hypertensives weighed more. Only one study 40 determined whether body weight was related to plasma NE; that study reported a nonsignificant correlation between NE and body-mass index.
Inpatients vs Outpatients
Twenty-nine studies reported mean hypertensive and normotensive group NE either exclusively in outpatients, inpatients, or both conditions analyzed separately. Among 15 inpatient studies, the mean hypertensive NE level was 281 pg/ml, compared with 209 pg/ml in the normotensives (t = 3.02, p < 0.01). Among 15 outpatient studies, the mean hypertensive NE level was 320 pg/ml, compared with 269 pg/ml in the normotensives (t = 3.22, p < 0.01). Five of the 15 inpatient and five of the 15 outpatient studies were positive. These identical proportions indicate that the likelihood of obtaining a significant H-N difference in NE was the same in inpatient and outpatient studies.
When normotensive outpatient groups were compared with normotensive inpatient groups, the outpatients showed a significantly higher mean NE level than the inpatients (269 vs 209 pg/ml, t = 2.23, p < 0.05). In contrast, hypertensive outpatient groups did not differ significantly from hypertensive inpatient groups in plasma NE.
Labile vs Established Hypertension
The nomenclature for patients with diastolic pressure occasionally above and occasionally below hypertensive criteria is muddled. In this review, I have classified this group as "borderline" hypertensive, regardless of the label used in the publications. I considered hypertensive groups to be "established" when the study reported that all blood pressure measurements showed diastolic pressures above the hypertensive criterion (usually 90 mm Hg).
A total of 38 studies reported NE levels in borderline or established hypertensive groups, or both analyzed separately. Across 19 borderline hypertensive groups, the mean NE level was 236 pg/ml -similar to the overall normotensive average value -while among 32 established hypertensive groups, the mean NE level was 298 pg/ml (t = 2.76, p < 0.01). When borderline and established hypertensive group values were compared with the corresponding normotensive control groups, 18 of 32 (56%) established hypertensive groups showed significantly greater NE than the controls, while only five of 19 (26%) borderline hypertensive groups showed greater NE than the controls (x 2 = 3.21, 0.05 <p < 0.10). In general, therefore, groups of established hypertensives had higher mean plasma NE than borderline hypertensives, and studies of established hypertensives tended to be positive, while studies of borderline hypertensives tended to be negative.
When relatively young (less than or equal to 40 years old) borderline and established hypertensive groups were compared with normotensive controls, a striking pattern emerged: While six of 12 (50%) young borderline hypertensive groups showed higher NE levels than the controls, 14 of 15 (83%) young established hypertensive groups showed significantly higher norepinephrine levels than controls (/ 2 = 4.44, p < 0.05). Thus, while young hypertensive groups as a whole showed significantly elevated resting plasma NE, young established hypertensive groups virtually always did.
Two studies by the same group 61 ' 62 measured NE in borderline hypertensives when their blood pressure exceeded and also when their blood pressure did not exceed the hypertensive criteria. Norepinephrine was lower and not significantly different from the normotensive control group value when the borderline hypertensives had pressures within the normal range.
Severity of Hypertension
Undoubtedly some unknown proportion of the reportedly "labile" hypertensive groups did not have labile blood pressure at all, but merely had mild enough hypertension that their diastolic pressure hovered around 90 mm Hg. The "labile" groups may also have included subjects who hyperreacted to the stress associated with venipuncture or the medical environment without actually having essential hypertension. If plasma NE varied with blood pressure, then the established hypertensives could have had higher NE due to their relatively high blood pressures, independent of lability.
Across 87 groups in which mean arterial pressure was reported, the average pressure-NE correlation was 0.24. Although NE correlated weakly positively with mean arterial pressure, differences in mean hypertensive arterial pressure did not differentiate positive from negative studies.
Twenty-eight studies commented on NE-blood pressure correlations in the hypertensive or normotensive groups or both. Twelve of 13 (92%) normotensive groups showed no significant NE-blood pressure correlation, while 10 of 20 (50%) hypertensive groups did report a significant correlation (x 2 = 4.71, p < 0.05). Two studies 62 -73 reported data relevant to possible differences between borderline and established hypertensives in NE-pressure correlations. In both, NE and blood pressure apparently were correlated significantly only in the established hypertensive groups.
Heart Rate
Group mean heart rate data presented in table 2 document slightly but consistently elevated heart rates in the hypertensive groups (mean difference = 6 bpm, t = 7.64, p< 0.001). Only three of 16 (19%) studies reporting significant H-N differences in heart rate were positive, and seven of 18 (39%) studies reporting no significant H-N differences in heart rate were positive. The likelihood of obtaining a significant H-N difference in NE, therefore, was independent of the likelihood of a significant H-N difference in heart rate.
Across five normotensive groups, NE did not correlate significantly with heart rate; in contrast, NE did correlate significantly with heart rate in five of six hypertensive groups (x 2 = 4.84, p < 0.05). Eight studies compared average heart rates of hypernoradrenergic and normonoradrenergic subgroups of hypertensives: the classification was based on NE in three studies, 12 In all eight studies, the mean heart rate of the hypernoradrenergic subgroup was higher than that of the corresponding normonoradrenergic subgroup. Unfortunately, despite the frequency of relatively high heart rates in the hypertensive population, no study considered the converse hypothesis -that hypertensives with relative tachycardia show increased plasma NE. The available data suggest that hypertensive -but not normotensive -groups showed positive NE-heart rate correlations, so that hypernoradrenergic hypertensives had relative tachycardia; but the frequency ot significant H-N differences in NE was independent of the frequency of significant H-N differences in heart rate.
Sodium Balance and Renin
Seventeen studies have commented on possible relationships between plasma renin activity or concentration and plasma NE in hypertensive groups. Eleven of the 17 reported no discernible relationship -either in the form of correlations or comparisons of subgroups classified according to renin activity -between plasma NE and renin. Ten of these 11 studies also reported no significant H-N differences in NE. In contrast, five of the six studies reporting significant NE-renin relationships also reported significant H-N differences in NE (x 2 = 5.76, p < 0.02). This rather surprising finding may be explained by the inclusion in positive studies of a greater proportion of high-renin hypertensives. 9 ' 27> M ' 73 Alternatively, positive studies may have included hypertensives still under the influence of diuretic therapy, since volume depletion should -at least temporarily -increase both renin activity and NE. The latter explanation is somewhat unlikely, since some studies in untreated hypertensives have reported significant renin-NE relationships.
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When sodium balance is uncontrolled, plasma renin activity can vary widely across individuals. Unfortunately, few studies have rigorously controlled sodium balance. Only 29 studies of NE commented at all about sodium intake. In the eight studies where sodium intake was unrestricted, as well as in the remainder of studies where sodium intake was controlled to varying degrees -from outpatient instructions without urinary sodium monitoring to inpatient metabolic ward conditions -no relationship was apparent between sodium intake and the frequency of significant H-N differences in NE.
Time Factors
I considered the following time factors: the time off antihypertensive medication before venipuncture; the length of fasting; the time of day; and the length of time the patient was supine prior to sampling. The mean time off antihypertensive therapy was 3 weeks in studies where the patients had been treated, with a range from 24 hours to 2 months. Separate analyses of studies in which medication was withheld less than or more than 2 weeks showed no difference in the frequency of positive results. However, the frequency of positive results was significantly greater in studies of previously treated hypertensives (65% vs 24%, x 2 = 6.76, p < 0.01).
Prolonged fasting in humans is known to increase plasma NE. 86 All of the nine studies where the patients were not fasting were negative; in contrast, 8 of 19 (42%) where the patients fasted -usually overnight -were positive (x 2 = 3.74, 0.05 < p < 0.10). The vast majority of studies involved phlebotomy in the morning. Oddly, of the six studies where blood sampling occurred after noon, five were positive, while of 32 studies where blood was drawn before noon,only eight were positive (x 2 = 4.95,p<0.05). When patients were supine less than or equal to 30 minutes, only nine of 34 (26%) studies were positive, while when they were supine longer than 30 minutes, 14 of 25 (56%) were positive (x 2 = 5.27, p < 0.05).
Control Groups
Because normotensive control NE levels were lower in positive than negative studies, both overall and specifically among the radioenzymatic studies, it is possible that factors in the selection, characteristics, or treatment of the controls helped to determine whether the results would be positive. Unfortunately, most studies did not describe the control group beyond mentioning that they were normotensive, so that acrossstudies statistical comparisons for factors of interest could not be done. A few findings were suggestive, however.
Studies using hospital or laboratory personnel as controls were invariably positive, 2 4 4 6 " while those using medically naive controls were usually negative. 1 ' 2i '• 3Si u Compared within studies, controls familiar with the medical environment had lower NE levels than nonacclimated controls. 4271 When the controls were not completely healthy, but were recuperating from various illnesses, or admitted for diagnostic testing, or suffering from diseases supposedly unrelated to the sympathetic nervous system, the results usually were negative.
18 -32 ' * 2 Selection factors operative in the normotensive control groups, therefore, could have produced artifactually positive or negative results.
Epinephrine Table 4 displays data derived from 31 comparative studies of plasma E in patients with essential hypertension and in normotensive controls. As with NE, the majority of studies (74%) reported higher E in the 
TABLE 4. Plasma Epinephrine in Resting, Supine Patients with Essential Hypertension and in Normotensive Controls
First author (ref) (12) DeChamplain (17) Eide (23) Eng (24) Esler (29) Franco-Morselli (31) Franco-Morselli (32) Fujiki (33) Henquet (36) Hjemdahl (38) Ibsen (41) Kjeldsen (45) Meier (58) Messerli (59 •Statistically significant hypertensive-normotensive difference in heart rate or C = COMT radioenzymatic; P = PNMT radioenzymatic; H = HPLC; F = epinephrine, with p < 0.05. rluorimetric.
hypertensive groups, and, as with NE, only 48% were positive. The summary data in table 1 demonstrate that the average H-N difference in E was quite small (13 pg/ ml), especially when compared with the average SD across individuals, which averaged about 80% of the mean for the hypertensive and normotensive groups. These two findings necessarily restrict inferences that can be drawn from the data. The results of the two studies with the highest hypertensive E levels are suspect: one calculated E from the difference between TC and NE;
12 the other used a liquid chromatographyelectrochemical technique where the validity and reliability of the procedure for measuring resting human E levels were not documented. 38 Virtually all the studies used the COMT radioenzymatic assay technique, so that fluorimetric-radioenzymatic comparisons could not be made.
Of eight studies reporting age-E correlations in hypertensive groups, none was significant. Among seven normotensive groups, E did not correlate significantly with age in four and correlated significantly negatively with age in three. The available literature therefore shows a contrast between typical normotensive age-NE and age-E trends, since NE tends to increase with age and E tends to decrease with age -if any agerelated trends are noticeable. A prediction from these findings is that, in contrast with plasma NE, plasma E levels would differentiate hypertensives from normo-tensives regardless of the age of the patients. Consistent with this hypothesis, four of nine (44%) studies where the hypertensives averaged less than or equal to 40 years old were positive with respect to E, and six of 14 (43%) studies where the hypertensives averaged more than 40 years old were positive.
Positive and negative studies could not be differentiated on the basis of hypertensive mean E values or on the basis of SD in the hypertensive or normotensive groups, but normotensive E levels were significantly lower in the positive than the negative studies (34 vs 51 pg/ml, t = 2.69, p < 0.05).
Regarding E-heart rate relationships, three studies have reported no significant E-heart rate correlation in normotensive groups; three of four hypertensive groups have shown significant E-heart rate relationships. Too few studies have commented on these relationships to conduct meaningful statistical tests across studies. In two studies, l4 '" however, E correlated significantly with heart rate in the hypertensive groups but not in the normotensive groups. In five studies where the mean hypertensive heart rate was greater than 77 bpm, all five studies were positive. The available data therefore indicate that plasma E is related to heart rate in hypertensive groups, so that studies where the hypertensives were relatively tachycardic tended to be positive with respect to E. None of four studies reporting E-pressure relationships reported a significant positive correlation in hypertensive or normotensive groups.
Of the 15 studies reporting significant H-N differences in E, only three also reported significant differences in NE. OTI the other hand, five studies reporting significant H-N differences in NE reported no significant differences in E. Thus, the likelihood of obtaining significant H-N differences in NE was virtually completely independent of the likelihood of obtaining significant differences in E. Dopamine Table 5 shows the results from the relatively few studies that have reported plasma free DA concentrations in patients with essential hypertension and normotensive controls. No study reported a significant H-N difference. Interindividual variability was quite large for this catecholamine. In view of the dearth of studies and lack of interindividual consistency, it is likely that the only widely used technique for measuring plasma DA, the COMT radioenzymatic assay, is not as reliable for measuring DA as for NE or E. Since dopamine exists in plasma predominantly in conjugated form, it is possible that steps in the COMT assay technique may deconjugate dopamine to a variable degree, or else other substances besides DA may interfere with the thin-layer chromatographic separation of this catecholamine. There is no convincing evidence for abnormal plasma-free DA levels in essential hypertension.
Total Catecholamlnes
Plasma "total catecholamines," probably NE, E, and DA, were reported in the studies listed in table 6 . The literature about TC is remarkably consistent: all the studies reported higher levels of TC in the hypertensive groups, and most of the time the H-N differences were statistically significant. When the hypertensives were relatively young (mean age less than 40 years old) or had relative tachycardia (heart rate more than 77 bpm), all the studies of TC were positive. This could have resulted from the previously described relationships between age and NE and between heart rate and E in hypertensive and normotensive groups.
Since the likelihood of obtaining significant H-N differences in NE was independent of the likelihood of obtaining significant H-N differences in E, would the sum of norepinephrine and epinephrine differentiate hypertensive from normotensive groups better than either variable alone? Across 32 studies where such a sum was obtainable, in 28 (86%) the sum was greater in the hypertensive than the normotensive group (t = 5.32, p < 0.001). Therefore, of 44 studies reporting either TC or NE plus E, 40 reported higher levels in the hypertensives ( fig. 2 ). The figure shows clearly that the largest H-N differences occurred when the hypertensive group mean value was high, again indicating that a variably represented hypernoradrenergic or hyperadrenergic (or both) subgroup exists in the overall hypertensive population. 
Controls Plasma Total Catecholamines in Resting, Supine Patients with Essential Hypertension and in Normotensive
First author (ref)
Chobanian (9) Christensen (10) Cousineau (12) Cousincau (13) DeChamplain (14) DeChamplain (15) DeChamplain (16) DeQuartro (19) DeQuattro (20) DeQuattro (21) Engelman (25 •Statistically significant hypertensive-normotensive difference in heart rate or total catecholamines with p < 0.05. C = COMT radioenzymatic; F = fluonmetric. Discussion Few areas of hypertension research have aroused so much interest and controversy as that dealing with the possible etiologic role of excessive activity of the sympathetic nervous system in essential hypertension. The introduction of adequately sensitive and specific techniques for measuring plasma catecholamines and evidence that plasma NE provides an indirect index of sympathetic neural activity promised to settle the issue quickly. A large body of literature has accumulated on the subject, but no consensus has emerged about whether patients with essential hypertension show elevated levels of plasma catecholamines.
So many studies have compared plasma catecholamines in hypertensive and normotensive groups that a statistical approach could be used in which each study provided single data points for the hypertensives and the normotensives, and comparisons across studies undertaken, to identify factors differentiating the positive from negative studies. With use of this approach, several consistencies in the literature can be highlighted, and a few conclusions drawn.
Across 64 studies, plasma NE levels were higher in hypertensive than normotensive groups about 80% of the time. Due to the relatively small average H-N difference in NE -about 55 pg/ml -compared with the large interindividual SD for NE, only about 40% of the studies reported statistically significant H-N differences. Hypertensive group NE levels in positive stud- CATECH0LAM1NES IN HYPERTENSlON/GoWsre/w ies were significantly higher than hypertensive NE levels in negative studies. This finding is consistent with the hypothesis that variably represented hypernoradrenergic patients displaced the distribution of NE values upward in positive studies.
Although hypertensives tended to be older than normotensives, the artifactual effects of poor age matching could not account for the obtained differences in norepinephrine between the hypertensive and normotensive groups. On the other hand, studies were much more likely to be positive when relatively young patients -40 years old or younger -were involved.
Studies of norepinephrine also were more likely to be positive when the hypertensives were consistently hypertensive, i.e., showed diastolic blood pressures above hypertensive criteria (usually 90 mm of Hg) on all blood pressure measurements, compared with studies of hypertensives where the blood pressure on occasion did not exceed hypertensive criteria. When the factors of patient age and consistency of blood pressure elevation were considered simultaneously, virtually all studies of young, established hypertensives were positive with respect to NE.
As with NE, the majority of studies of plasma epinephrine showed higher E levels in the hypertensive than the normotensive group, and, as with NE, only about 40% of the studies reported statistically significant H-N differences. The likelihood of obtaining positive results when E was measured was independent of the age of the patients. On the other hand, when the hypertensives on average were relatively tachycardic, the studies were invariably positive with respect to E.
The likelihood that a study was positive with respect to NE was virtually completely independent of the likelihood that it was positive with respect to E. Because of this, when the sum of NE and E was considered, the vast majority of studies reported a higher sum in the hypertensive than the normotensive groups. Further, when "total catecholamines" were measured, hypertensives always showed higher levels than normotensives, usually significantly so.
These results taken together lead to the suggestions that: 1) young, consistently hypertensive patients include some with excessive plasma NE; 2) tachycardic hypertensives -regardless of age -include some with excessive plasma E; and 3) patients with elevated NE levels do not necessarily show altered E levels, and vice versa, so that the sum of NE and E differentiates hypertensives from normotensives to a greater extent than levels of either substance alone.
To the extent that circulating NE and E levels provide indices of sympathetic neural and sympathoadrenomedullary activity, the elevated levels seen in some hypertensives suggest that abnormalities in sympathetic neural or sympathoadrenomedullary activity occur in those patients.
Although, for simplicity, the results were analyzed in terms of hypothesized "hypernoradrenergic" or "hyperadrenergic" subgroups among the hypertensive population, the data did not allow a pathophysiologic differentiation between distinct subgroups versus individuals with high values along a single continuum of catecholamine levels.
When one considers the complex methodological problems inherent in research involving plasma catecholamine determinations -the assay techniques, the ultra-low concentrations, and the susceptibility to common environmental influences -it is not surprising that only analytical review of a large number of studies can identify factors associated with statistically significant H-N differences. In the future, with more careful environmental controls, unbiased patient selection, improved assay techniques, and more directed hypotheses, studies should agree more.
